CRDF
Cardiff OncologyCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
CRDF vs peer average
60/100
CRDF vs. peer average (C vs. D)
Grade spread
B 1 · C 3 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
CGTX is the first available peer comparator.
Similar-size clinical-stage biotech screening comparator only; the packet does not establish comparable indication, mechanism, or trial economics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRDF
Cardiff Oncology
CGTX
Cognition Therapeutics
Grade
C
D
Momentum
91
61
Value
41
41
Sentiment
60
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs CGTX
CRDF / CGTX
Grade Position
In line
CRDF vs. peer average (C vs. D)
60/100
Momentum
91
CRDFValue
41
CRDFSentiment
60
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRDF
CGTX is the first peer returned for this comparison set.